Company Filing History:
1 out of 183 
1 out of 1 Years Active: 2019
Title: Innovations of Chung-Sheng Shi in Osteoporosis Treatment
Introduction
Chung-Sheng Shi is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of osteoporosis. His innovative approach focuses on the inhibition of neddylation, which plays a crucial role in bone resorption.
Latest Patents
Chung-Sheng Shi holds a patent for a method of preventing or treating osteoporosis by neddylation inhibitor. The patent discloses a method that involves administering an effective amount of an inhibitor to a subject in need of treatment. This method aims to prevent and/or treat abnormal bone resorption and osteoporosis. The neddylation inhibitor mentioned in the patent includes NAE inhibitors, such as MLN4924.
Career Highlights
Throughout his career, Chung-Sheng Shi has been associated with prestigious institutions, including Chang Gung University and Chiayi Chang Gung Memorial Hospital. His work in these organizations has allowed him to advance his research and contribute to the medical community.
Collaborations
Chung-Sheng Shi has collaborated with notable colleagues, including Meng-Huang Wu and Kuo-Ti Peng. These collaborations have further enriched his research and innovations in the field of osteoporosis treatment.
Conclusion
Chung-Sheng Shi's innovative methods for treating osteoporosis highlight his dedication to advancing medical science. His contributions through patents and collaborations demonstrate the impact of his work on improving health outcomes for individuals suffering from bone-related conditions.